Another similar retrospective study revealed slightly less hearing decline among 26 patients with vestibular schwannomas who were taking losartan, though this did not reach statistical significance, highlighting the need for higher powered prospective studies with longer-term follow-up [ 60 ].
← all excerpts
Repurposing Renin-Angiotensin System Drugs for the Treatment of Audiovestibular Disorders.
1
—
—